Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Oncology News

ESMO oncology news ensures that you are always kept up to date with the latest developments that affect you and your daily practice.

Make sure you check these pages frequently, or sign up to our newsletter.

Filter by:
Reset

1575 results

Anticancer agents & Biologic therapy;  Breast cancer;  Gastrointestinal cancers;  Genitourinary cancers;  Gynaecologic malignancies;  Lung and other thoracic tumours

EMA Recommends Granting a Marketing Authorisation for Biosimilar Bevacizumab

It is intended for the treatment of carcinoma of the colon or rectum, breast cancer, NSCLC, RCC, epithelial ovarian cancer, and carcinoma of the cervix

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings